Fused bicyclic imidazoles

A compound of formula (I)

• wherein ring B and the imidazole to which it is fused form a ring system selected from
• wherein
• R1 is hydrogen, 1-4C-alkyl, halogen, amino, —SR2, trifluoromethyl, cyano, 3-7C-cycloalkyl, 2-4C-alkenyl, 2-4C-alkynyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, mono- or di-1-4C-alkylamino, mono- or di-1-4C-alkylaminocarbonyl, —C(NH)NH2, —C(O)NH2 or —C(O)OR10
• R2 is hydrogen, 1-4C-alkyl or 3-7C-cycloalkyl,
• R3 is hydrogen, 1-4C-alkyl or halogen,
• R4 is phenyl substituted by R5, unsubstituted phenyl, thienyl, pyridinyl, thiazolyl or oxazolyl,
• R5 is 1-4C-alkyl, halogen or 1-4C-alkoxy,
• R6 is hydrogen or 1-4C-alkyl,
• R7 is —W—Y,
• W is a monocyclic 5-membered heteroarylene comprising 1 nitrogen atom and optionally 1 or 2 further heteroatoms independently selected from oxygen, nitrogen and sulphur,
• and wherein the heteroarylene is optionally substituted by R8,
• R8 is 1-4C-alkyl or 3-7C-cycloalkyl,
• Y is phenyl or a monocyclic 5- or 6-membered heteroaryl comprising 1 nitrogen atom and optionally 1 or 2 further heteroatoms independently selected from oxygen, nitrogen, sulphur
• and wherein the heteroaryl is optionally substituted by R9,
• R9 is 1-4C-alkyl, 1-4C-alkoxy or halogen,
• R10 is hydrogen or 1-4C-alkyl,
• or a salt, particularly a pharmaceutically acceptable salt, a tautomer, or a stereoisomer of said compound, or a salt, particularly a pharmaceutically acceptable salt, of said tautomer or said stereoisomer.